FDA's Patrick Cournoyer Says If The Products Are Going To Stay On The Market We Need An Oversight Framework That Works For Them So We Can Understand These Risks And Manage Them
Portfolio Pulse from Benzinga Newsdesk
Patrick Cournoyer from the FDA has stated that for products to remain on the market, an effective oversight framework is needed to understand and manage associated risks. This statement was made during a Benzinga subscriber event.
September 28, 2023 | 2:21 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The FDA's call for an effective oversight framework could impact the AdvisorShares Pure US Cannabis ETF (MSOS) as it may lead to stricter regulations for cannabis products.
The FDA's call for an effective oversight framework could lead to stricter regulations for cannabis products. As MSOS is an ETF that tracks the performance of US companies in the cannabis industry, any regulatory changes could impact the performance of the companies in the ETF, and thus the ETF itself.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50